Mexico - Latin America Antidiabetics Market, 2026-2033

Name: Mexico - Latin America Antidiabetics Market
Creator: Grand View Research
License: https://www.grandviewresearch.com/horizon/info/terms-of-use

The antidiabetics market in Mexico - Latin America is expected to reach a projected revenue of US$ 3,377.6 million by 2033. A compound annual growth rate of 10.6% is expected of Mexico - Latin America antidiabetics market from 2026 to 2033.

Pharmaceuticals
- Metabolic Disorders Treatment
  - antidiabetics market

Mexico antidiabetics drug class outlook (Revenue, USD million, 2021-2033)
- Insulin
  - Long-acting insulin
  - Premix insulin
  - Fast-acting insulin
  - Human insulin
- GLP-1 Receptor Agonists
- DPP- 4 Inhibitors
- SGLT2 Inhibitors
- Others
Mexico antidiabetics diabetes type outlook (Revenue, USD million, 2021-2033)
- Type 1
- Type 2
Mexico antidiabetics distribution channel outlook (Revenue, USD million, 2021-2033)
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
Mexico antidiabetics route of administration outlook (Revenue, USD million, 2021-2033)
- Oral
- Subcutaneous
- Intravenous

Mexico - Latin America Antidiabetics Market, 2026-2033

Data Tree

Sign up - it's easy, and free!